Gene expression within the central nervous system is regulated by complex interactions of DNA-binding proteins, among which are the POU domain-containing proteins, which are distantly related to homeobox proteins. These POU domain-containing proteins have been implicated in control of transcription and replication within the central nervous system. We used degenerate primers with the PCR to isolate another POU domain-containing cDNA, RHS2, from hypothalamic RNA. Isolation of a putative full-length cDNA was accomplished by using serial dilutions of a hypothalamic cDNA library grown on solid medium. This member ofthe class HI POU family is expressed in rats from embryonic day 11.5 into adulthood, being especially prominent in the brain. We performed double-labeling hybridization histochemistry and determined that RHS2 is coexpressed with a variety of neuropeptides in medium-sized neurons in the caudate putamen and with dynorphin in the paraventricular and supraoptic nuclei of the hypothalamus. Expression ofRHS2 in the caudate putamen was increased by elimination of its nigrostriatal dopaminergic innervation.
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Many distinct families and subclasses of DNA-binding transcription factors have been described in the brain (for review, see refs. 1 and 2). Among these families is the homeoboxrelated POU domain-containing proteins. These proteins, acting as monomers, or homodimers and heterodimers with other POU proteins or DNA-binding proteins, appear to regulate cell-specific gene expression, cell fates, and even replication (for review, see refs. 3 and 4). Furthermore, most of the identified POU proteins are expressed in various adult tissues, including brain, where they exhibit different patterns of expression and likely regulate gene expression, acting as positive or negative transcription factors. For example, SCIP appears to repress myelin-specific genes (5, 6), Pit-1 transactivates the growth hormone and prolactin genes in the anterior pituitary (7, 8) , and Cfla transactivates the dopamine decarboxylase gene in Drosophila neurons (9) .
For several years, we have been interested in regulation of gene expression in the hypothalamus, especially in the paraventricular (PVN) and supraoptic (SON) nuclei. Recently, He et al. (10) identified several POU domain genes expressed in mammalian developing and adult brains, some of which are expressed in the hypothalamus. To identify specific transcription factors involved in regulation of genes expressed in these areas, we examined mRNA from the PVN and SON and cloned a POU domain-containing cDNA, RHS2. Subsequently, we isolated a putative full-length clone for RHS2 from a rat hypothalamic cDNA library and we report here its sequence and expression patterns in developing and adult rat.*
MATERIALS AND METHODS
Cloning Strategy. Total RNA was isolated from the PVN and SON of 11-g preweanling rats using 500-pum-diameter punches (11) and the method of Chomczynski and Sacchi (12) . The RNA was primed with a poly(dT) primer and the first strand was synthesized with avian myeloblastosis virus reverse transcriptase (BRL). Two degenerate primers based on the sequences of the N terminus and C terminus of the
were then used to amplify DNA by PCR according to the manufacturer (Perkin-Elmer/Cetus) with 30 cycles of 940C for 1 min, 55°C for 1 min, and 72°C for 3 min. A 380-base-pair (bp) band was extracted and subcloned into pGEM3Z (Promega) and clones were sequenced by the chaintermination method (13) using a Sequenase kit (United States Biochemical). One clone, PVN19, displaying a high amino acid homology with the POU domain of other POU proteins, was isolated.
Hypothalamic mRNA was isolated from rats given 2% saline to drink for 7 days and a cDNA library with 2 x 107 independent recombinants was constructed according to the method of Okayama et al. (ref. 14; M. J. Brownstein and W.S.Y., unpublished results). Initially, the library was screened by a sequential subdivision method in LB/ ampicillin cultures as described by Bonner et al. (15) . However, we were not able to follow our clone further than the second subdivision, probably because of a growth disadvantage. To overcome this problem, we amplified our sublibraries on LB/ampicillin plates instead of in broth.
Two primers, PVN19.3 and PVN19.4 (5'-CACGTAC-CACTTCTTTCTCC-3' and 5'-CGACGTGGGGCTGGCAT-TGG-3'), targeted to either end of the PVN19 PCR fragment, were then used to screen the library. Pools from sequential subdivisions of the library (106, 2.5 x 105, 2.5 x 104, and 2.5 x 103 recombinants per pool) were plated on LB/ampicillin plates and grown overnight at 37°C. The bacteria were scraped off and resuspended in LB broth, and the plasmid DNA was isolated. PCRs (30 cycles of 94°C for 1 min, 60°C for 2 min, and 72°C for 1.5 min) were then performed with PVN19.3 and PVN19.4 primers on the plasmid DNA to follow pools containing the specific POU domain sequence. The initial PVN19 PCR fragment was then labeled with random primers (16) the "5S-labeled antisense probe (for RHS2) and igoxigenin-labeled antisense probes (for enkephce P, dynorphin, oxytocin, or neurokinin B) in the buffer. Slides were processed as described being washed four times for 30 min in 0.2x SSC sections were rinsed twice in buffer 1 (100 mM ) mM NaCl, pH 7.5) for 5 min, and then in buffer 3% normal goat serum and 0.3% Triton X-100 for r 5 hr of incubation with alkaline phosphataseanti-digoxigenin antiserum (Boehringer MannIin 3% normal goat serum/0.3% Triton X-100 in sections were rinsed twice for 10 min in buffer Dr 5 min in buffer 3 (100 mM Tris.HCl/100 mM I MgC12, pH 9.5). The sections were then incught at room temperature in the dark in buffer 3 nitroblue tetrazolium salt (0.34 mg/ml) and iloro-3-indolyl phosphate toluidinium salt (0.18 T/BCIP; Boehringer Mannheim). Sections were for 5 Quantitation of RHS2 Expression. To examine RHS2 expression in rats with unilateral 6-hydroxydopamine injections into the substantia nigra, quantitative hybridization histochemistry was performed with a Fujix Bas2000 Image System (Fujifilm I & I, Stamford, CT). The intensity of labeling was measured in the caudate putamen and in the accumbens nucleus of the ipsilateral striatum and was compared to the contralateral side after subtraction of the background signal (n = 10). Values were expressed in arbitrary units of radioactivity. Statistical analyses were performed with a paired Student's t test.
RESULTS
The RHS2 cDNA. This cDNA encodes a protein belonging to class III of the POU protein family (10) . The RHS2 insert is -3.8 kb long and contains an open reading frame of 1083 bp encoding 361 amino acids, beginning with the first methionine (Fig. 1) , and predicting a molecular mass of -43 kDa. A potential N-linked glycosylation site is present at Asn-121. Northern analysis showed RHS2 transcripts of =3.8 kb in the rat brain but none was detected in skeletal muscle, liver, spleen, small intestine, thymus, kidney, testis, or lung (data not shown).
RHS2 mRNA Distribution During Development. RHS2 mRNA was detected in the rat from E11.5 onward. At this stage, RHS2 transcripts were prominent throughout the developing neuraxis, from the ventricular germinal zone to the marginal layer. At E13.5, RHS2 transcripts were conspicuous throughout the neuraxis and otic vesicles. By E15.5 ( Fig. 2) , RHS2 transcripts were largely confined to the central nervous system and otic vesicles but were also present in the outer sheath cells of the whisker roots. The same patterns held through E19.5 (Fig. 2) , with the basal telencephalon (caudate putamen) being especially prominent. In the cere -FIG. 3 . Distribution of RHS2 mRNA in sagittal (A and B) and coronal (C-F) sections from adult rat brain. Hybridization histochemistry was performed with a 35S-labeled RNA probe from the 515-bp Nco I restriction fragment. Antisense probes were used in A and C-F; sense probe was used in B. RHS2 mRNA was especially prominent in the ventricular ependyma (E), olfactory bulb (Ob), caudate putamen (CP), accumbens nucleus (Acb), olfactory tubercle (Ot; celldense layer and islands of Calleja), PVN and SON, habenula (Hb), and cingulate cortex (Cg). Lower levels of RHS2 mRNA were also detected in the frontal (Fr) and parietal (Pa) RHS2 mRNA Distribution in Adult Rat Brain. RHS2 mRNA was found prominently in the glomerular and internal granular layers of the olfactory bulb as well as the anterior olfactory nucleus, olfactory tubercle (cell dense layer, islands of Calleja, and cell dense clusters), cingulate cortex, neocortex (especially frontal and parietal), caudate putamen, accumbens nucleus, PVN (magnocellular and parvocellular neurons), SON, arcuate nucleus, medial habenula, and ventricular ependyma of the olfactory and lateral ventricles (Fig.  3) . Within the striatum, the intensity of labeling was higher ventrally (accumbens nucleus) than dorsally (caudate putamen). RHS2 was also expressed in the amygdala, pyramidal, and granule cells of the hippocampal formation, parasubiculum, substantia nigra (pars compacta), and cerebellar Purkinje and granular cells. A sense 3"S-labeled probe gave only background signals on adjacent sections in all these areas.
To learn more about cells in the hypothalamus, caudate putamen, and accumbens nucleus in which the RHS2 POU protein was expressed, we developed a double-labeling procedure using 35S-and digoxigenin-labeled RNA probes to identify neuropeptide transcripts in neurons expressing the RHS2 gene (Fig. 4) . Double-labeling experiments showed that RHS2 mRNA was not detected in neurons of the PVN or SON containing oxytocin mRNA. In contrast, RHS2 mRNA was detected in magnocellular neurons of the PVN and SON that contained dynorphin mRNA. In the striatum, RHS2 mRNA was detected mainly in medium-sized neurons, with a higher level of expression ventrally and medially Effects of Dopamine Depletion on RNS2 Gene Epession. As expected, after nigral 6-hydroxydopamine lesions, enkephalin mRNA levels were increased in the ipsilateral caudate putamen and accumbens nucleus, respectively, by 108% (P < 0.001) and 43% (P < 0.01). The amount of RHS2 mRNA was also increased in the ipsilateral caudate putamen by 30% (P < 0.001), whereas no change was found in the accumbens nucleus.
DISCUSSION
The newly discovered POU domain-containing cDNA, RHS2, based on sequence similarities within the POU domain, encodes a class III POU transcription factor (10) . The sequence homologies at the amino acid level within the POU domain range from 92% to 95% with the other mammalian class III POU proteins expressed in the brain. The predicted 361 amino acid open reading frame of the RHS2 clone is based on the assignment of the initial methionine by consensus (24) . Remarkably, our sequence exhibits 100o amino acid identity with the mouse homolog, Brain4 (25) . XLPOU2 appears to be the Xenopus homolog, having 89.7% identity over the published sequence (26) . Interestingly, RHS2, unlike other class III POU proteins with available sequence information [e.g., SCIP (27) and Cfl-a (9)], has no extensive homopolymeric stretches or over-representations of particular amino acids.
Despite the sequence similarities with Brain-i, Brain-2, SCIP, and RHSJ [another putative class III POU domaincontaining cDNA isolated in our laboratory (ref. 28; GenBank accession no. M84644)], and despite regions of overlap in expression, RHS2 exhibits unique expression patterns in developing rat and adult rat brain. For example, RHS2 is prominently expressed in the striatum, unlike Brain-i and Brain-2, and in the PVN, SON, and ventricular ependyma, unlike SCIP (Tst-J) (10 (3) . It is also possible that these subsets could receive and/or dispatch signals in a unified fashion. To learn whether RHS2 expression can be regulated in the adult, we investigated whether RHS2 expression is under dopaminergic control of the nigrostriatal pathway. As expected (19), 6-hydroxydopamine lesions elevated enkephalin expression ipsilaterally in the caudate putamen and accumbens nucleus. RHS2 expression in adjacent sections was increased in the caudate putamen, suggesting a role for RHS2 in regulation of gene expression mediated by dopamine. Since lesions of the substantia nigra mainly affect dopaminergic projections to the caudate putamen and the increase in enkephalin expression was lower in the accumbens nucleus, we cannot exclude the fact that a more extensive dopamine depletion of the accumbens nucleus would elevate RHS2 expression there. Further experiments with lesions that include the ventral tegmental area, which projects mainly to the accumbens nucleus, should answer this question. It is possible that selective manipulation of the dopaminergic innervation of the striatum with selective agents will identify responsive subsets of neurons that express RHS2-e.g., those that express a particular dopamine receptor subtype (17, 29) . In any case, our results suggest that RHS2 is involved, directly or indirectly, in striatal gene regulation by dopamine.
Our anatomical, especially double-labeling, and physiological data suggest potential genes that may be regulated by
